Bristol Myers Squibb names Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer Ruchika Sharma7 May 2025 11:15 AM ISTPrinceton: Bristol Myers Squibb has announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy...
Aurobindo Pharma arm Eugia Pharma Specialities gets USFDA nod for cancer drug Ruchika Sharma23 April 2025 12:53 PM ISTHyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval...
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb Ruchika Sharma18 April 2025 11:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for...
Mavacamten Misses Primary Endpoints in Phase 3 Trial for Non-Obstructive HCM Dr. Kamal Kant Kohli17 April 2025 8:00 AM ISTBristol Myers Squibb announced that mavacamten did not achieve statistical significance in meeting the dual primary endpoints in the Phase 3...
Bristol Myers Squibb heart disease drug fails to meet main goals in late-stage study Ruchika Sharma16 April 2025 9:30 AM ISTPrinceton: Bristol Myers Squibb has announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult...
Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit Ruchika Sharma13 April 2025 11:00 AM ISTA federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...
Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension Ruchika Sharma11 April 2025 11:30 AM ISTMumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...
Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1 Ruchika Sharma30 March 2025 12:15 PM ISTBristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across Multiple Solid Tumor Indications Ruchika Sharma29 March 2025 5:47 PM ISTPrinceton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
CDSCO Panel Approves Bristol Myers Squibb's Protocol Amendment Proposal to study Anti-cancer Drug Iberdomide Dr. Divya Colin21 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the Bristol Myers...
Bristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma Ruchika Sharma16 March 2025 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi (lisocabtagene...
Bristol Myers Squibb to acquire 2seventy bio for USD 286 million Ruchika Sharma14 March 2025 12:30 PM ISTCambridge: 2seventy bio, Inc. has announced a definitive merger agreement under whichBristol Myers Squibb will acquire all of the...
